Cancer as a Systemic Process: A Comprehensive and Regenerative Approach

Written by Dr. Domingo Guerra

The word cancer itself is terrifying due to the many consequences it entails. Not only because of its high mortality rate, but also because of the set of physical and functional processes that accompany the disease. In many cases, the patient faces intense and, at times, difficult-to-control pain, in addition to profound weakness resulting from mitochondrial damage, atrophy, and the progressive deterioration of various organs.

This systemic process can trigger severe anemia, states of hyperoxidation that promote widespread inflammation, marked malnutrition, profound metabolic alterations, and a massive loss of energy reserves and organic tissues. All of this not only compromises the quality of life but also progressively weakens the body’s ability to respond to the disease.

While conventional therapies have represented a significant advance in cancer treatment, they often generate additional complications that worsen the deterioration inherent in cancer. Although their toxicity has improved over time, these treatments are far from comfortable and, in many cases, are rejected by patients. Added to this is a key challenge: the high resistance of tumors, a product of cancer’s ability to produce enzymes and proteins that neutralize the action of these drugs and, in some cases, render the tumor virtually undetectable to the immune system.

In this context, new therapies are emerging that offer results that, for many patients, seem almost extraordinary. On the one hand, they act in a targeted manner on cancer cells; on the other, they promote the regeneration of the body, even impacting a reduction in biological age. As a result, the person not only faces the disease with greater strength but also regains vitality, resistance, and functionality. These treatments are not developed sequentially, but rather act through different therapeutic axes that intervene simultaneously on the main pathological mechanisms of cancer:

• An axis focused on the direct attack of tumor cells by reprogramming cell apoptosis, or cell death determined by genetic mechanisms.

• An axis based on the use of cell signaling molecules that act on the membrane of cancer cells, mutated DNA, and the systems that produce abnormal proteins that protect or reproduce tumors, also affecting those proteins involved in metastasis.

• An axis centered on strengthening the immune system, restoring its lost functional competence through multiple approaches that stimulate antibody production, facilitate tumor identification by the immune system, and increase both the number and effectiveness of key cells such as macrophages, monocytes, helper T cells, and natural killer cells. In this way, these therapies not only disable the mechanisms that make tumors resistant to drug treatments, but also interfere with the factors that promote their reproduction and their ability to evade the immune response.
At the same time, the regenerative approach works by repairing DNA and mitochondria, renewing the altered organelles of healthy cells, and intensifying the production of structural proteins, enzymes, and anabolic hormones responsible for the formation of new tissues. All of this results in a general strengthening of the body.

This process not only reverses the weakness and exhaustion characteristic of the disease, but in many cases leads to energy and strength levels higher than those prior to diagnosis. Improvements are observed in memory, cognitive ability, social relationships, and emotional state, associated with increased levels of endorphins, serotonin, and dopamine. Furthermore, these changes are linked to a longer life expectancy, related to the lengthening of telomeres, considered the body’s biological clock.